跳至主要内容
临床试验/NCT03504189
NCT03504189已完成不适用

Clinical Study Evaluating the Safety of PregSense and Comparative Performance of PregSense Versus CTG in Prenatal Monitoring of Pregnant Subjects

Nuvo-Group, Ltd.6 个研究点 分布在 3 个国家目标入组 151 人开始时间: 2018年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
151
试验地点
6
主要终点
Maternal Heart Rate

研究概览

简要总结

This clinical study will evaluate the safety of PregSense™ and Comparative Performance of PregSense™ versus CTG in Prenatal Monitoring of Pregnant subjects.

详细描述

PregSense™ is a maternal-fetal monitor that non-invasively measures and displays fetal heart rate, maternal hear rate and uterine contractions. This study will be performed to collect and digitally record data from PregSense™ and the standard of care (CTG) in order to provide evidence of safety and agreement between PregSense™ and the gold standard NST device.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Female age between 18-50
  • Gestational age > 32 + 0 weeks
  • Singleton gestation
  • Ability to understand and sign informed consent

排除标准

  • BMI (Body Mass Index) ≥ 45 and ≤15 prior pregnancy
  • Multiple gestation
  • Uncontrolled Hypertension
  • Fetal Anomaly
  • Subjects with skin problems in the abdominal area (such as flesh wounds, cuts in the skin, skin rashes, etc.)
  • Subjects with implanted electronic devices (pacemaker, defibrillator, etc.)
  • Subjects who, in the judgement of the investigator, are likely to be non-compliant or uncooperative during the study

结局指标

主要结局

Maternal Heart Rate

时间窗: 30 MInutes

Provide evidence of safety and agreement between MHR collected via the PregSense™ and the standard of care devices (i.e. CTG)

Fetal Heart Rate

时间窗: 30 Minutes

Provide evidence of safety and FHR agreement between PregSense™ and the standard of care devices (i.e. CTG)

次要结局

  • Uterine Contractions(30 Minutes)

研究者

发起方
Nuvo-Group, Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验